High nuclear expression of protein arginine methyltransferase‐5 is a potentially useful marker to estimate submucosal invasion in endoscopically resected early colorectal carcinoma. (6th August 2015)

• Record Type: Journal Article
• Authors: Pak, Min Gyoung; Lee, Hyoun Wook; Roh, Mee Sook
• Is Part Of: Pathology international. Volume 65:Number 10(2015:Oct.)
• Page Start: 541
• Page End: 548
• Publication Date: 2015-08-06
• Subjects: Pathology -- Periodicals; 616.07
• DOI: 10.1111/pin.12338
• Languages: English
• ISSNs: 1320-5463

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Protein arginine methyltransferase‐5 (PRMT5), a major type II arginine methyltransferase, is an important epigenetic modifier with oncogene‐like properties because of its ability to repress the expression of tumor suppressor genes. We determined the correlations between PRMT5 expression or its cellular localization and malignant progression, with special reference to invasiveness, in colorectal adenomas and early colorectal carcinomas (CRCs). We performed immunohistochemical detection of PRMT5 in 108 endoscopically resected tissue samples (6 adenomas with low‐grade dysplasia, 34 adenomas with high‐grade dysplasia, 30 intramucosal carcinomas, and 38 submucosal invasive carcinomas). Early CRC (55 of 68, 80.9%) showed more frequent nuclear expression of PRMT5 than adenoma (15 of 40, 37.5%) (<italic>P</italic> &lt; 0.001). Furthermore, high (strong staining in ≥ 50% of nuclei) nuclear expression of PRMT5 was more common in submucosal invasive carcinoma (21 of 38, 55.3%) than in intramucosal carcinoma (9 of 30, 30.0%) (<italic>P</italic> = 0.037). In conclusion, our data suggests that high nuclear expression of PRMT5 is a potentially useful marker for estimating submucosal invasion of early CRC in endoscopically resected specimens.</p> </abstract>